Legendary value investors (like billionaire Seth Klarman) are recognizing that the genomics revolution has supercharged the biotech industry, radically improving the odds of creating successful new drugs. As young biotech firms develop exciting new compounds, larger companies fight over them, eventually offering billions of dollars for companies that do not yet even have drugs on the market.
Learn More About Top-Performing Biotech Firms
Aucun commentaire:
Enregistrer un commentaire